Synthes' acquisition by Johnson & Johnson now completed

Johnson & Johnson announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson. The completion of the Synthes acquisition creates a most innovative and comprehensive orthopaedics business.

Johnson & Johnson was advised as to Swiss law by Pestalozzi. The Pestalozzi team was headed by Christoph R. Ramstein (corporate/tax) and Christoph G. Lang (M&A) and comprised among other partners Silvia Zimmermann for tax, Martin Müller for executive compensation and benefits and Lorenza Ferrari Hofer on regulatory and IP law.